Raju Prasad insider trades

Open-market stock purchases and sales by Raju Prasad, Chief Financial Officer at CRISPR Therapeutics AG, from SEC Form 4 filings since Mar 14, 2023.

Recent trades

DateStockTradeValue
Aug 7, 2026CRSP CRISPR Therapeutics AGSold (not open market)—
May 29, 2026CRSP CRISPR Therapeutics AGBought (not open market)—
Mar 23, 2026CRSP CRISPR Therapeutics AGSold$173K
Mar 20, 2026CRSP CRISPR Therapeutics AGBought (not open market)—
Mar 20, 2026CRSP CRISPR Therapeutics AGBought (not open market)—
Mar 20, 2026CRSP CRISPR Therapeutics AGBought (not open market)—
Mar 16, 2026CRSP CRISPR Therapeutics AGSold$282K
Mar 16, 2026CRSP CRISPR Therapeutics AGSold$194K
Mar 16, 2026CRSP CRISPR Therapeutics AGSold (not open market)—
Mar 14, 2026CRSP CRISPR Therapeutics AGBought (not open market)—
Mar 14, 2026CRSP CRISPR Therapeutics AGBought (not open market)—
Jan 22, 2026CRSP CRISPR Therapeutics AGSold$2.1M
Jan 22, 2026CRSP CRISPR Therapeutics AGBought (not open market)—
Jan 6, 2026CRSP CRISPR Therapeutics AGSold$1.1M
Jan 6, 2026CRSP CRISPR Therapeutics AGSold$300K
Jan 6, 2026CRSP CRISPR Therapeutics AGSold$347K
Jan 6, 2026CRSP CRISPR Therapeutics AGBought (not open market)—
Jan 6, 2026CRSP CRISPR Therapeutics AGBought (not open market)—
Dec 22, 2025CRSP CRISPR Therapeutics AGSold$308K
Dec 22, 2025CRSP CRISPR Therapeutics AGSold$56.9K
Dec 22, 2025CRSP CRISPR Therapeutics AGSold$194K

Companies traded

  • CRSP CRISPR Therapeutics AG: 13 sales, last Aug 7, 2026

Get free alerts when Raju Prasad files a new trade →